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Abstract
Aim The aim of this study was to determine the oncologic value of omentectomy in patients undergoing gastrectomy for gastric
cancer.
Methods All consecutive patients with gastric cancer that underwent gastrectomy with curative intent between April 2012 and
August 2015 were prospectively analyzed. The greater omentum was separately marked during operation and pathologically
evaluated for the presence of omental lymph nodes and tumor deposits.
Results In total, 50 patients were included. The greater omentum harbored lymph nodes in nine (18 %) patients. The omental
lymph nodes contained metastases in one (2 %) patient, still free of disease after 20 months. Omental tumor deposits were found
in four (8 %) patients; one died <30 days postoperative and three developed peritoneal carcinomatosa after 4, 4, and 8 months.
Patients with omental tumor deposits had a significantly reduced 1-year disease-free survival compared to patients without tumor
deposits (0 vs. 58.7 %, p=0.003). No predictive factors for omental tumor involvement could be identified.
Conclusion Omental lymph node metastases or tumor deposits are present in 10 % of Western European patients undergoing
gastrectomy for gastric cancer. Omentectomy has a prognostic and oncologic value in the curative treatment of patients with
gastric cancer. As no predictive factors for omental tumor involvement could be identified, omentectomy should be the standard
in gastrectomy for gastric cancer patients.
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Introduction
The standard of care for the curative treatment of gastric ade-
nocarcinoma is surgical resection with perioperative
chemotherapy.1
, 2 The oncologic importance of omentectomy
during total and distal gastrectomy remains unclear. The
European, American, and Japanese guidelines for the treat-
ment of gastric adenocarcinoma have not reached uniform
consensus with respect to omentectomy. The European guide-
lines do not give any advice regarding omentectomy,3
, 4
whereas the most recent American guidelines advise to resect
both the greater and lesser omentum.5 Alternatively, the
Japanese Gastric Cancer Association recommends preserva-
tion of the greater omentum at >3 cm from the gastroepiploic
arcade for patients with T1-T2 tumors and total omentectomy
for patients with T3-T4 tumors.6 The inconsistency between
guidelines on this topic reflects the lack of studies that evalu-
ate the patterns of lymphatic spread and omental tumor in-
volvement during primary curative surgery for gastric cancer.
The function of the greater omentum is to localize and
encapsulate the sites of infection to limit intra-abdominal
disease.7
, 8 Omentectomy is an additional surgical procedure
to gastrectomy, which may lead to longer operation time and
might add to morbidity.8
–10 The aim of this study was to
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evaluate the value of the resection of the greater omentum in
Western patients that underwent gastrectomywith omentectomy
at curative intent for gastric adenocarcinoma.
Material and Methods
Patients
All consecutive patients who underwent a curative gastrecto-
my with omentectomy for gastric adenocarcinoma at the
University Medical Center Utrecht between April 2012 and
August 2015 were included. In this prospective cohort, the
gastrocolic ligament and the actual greater omentum were
dissected and marked separately during surgery. The greater
omentum was divided in four quadrants for pathological eval-
uation of the patterns of lymphatic spread and tumor deposi-
tion. The surgical resection and marking and the pathological
processing and analysis of the specimen were performed ac-
cording to a standardized protocol. Clinical data were re-
trieved from the medical records. Survival status was evaluat-
ed during follow-up and additionally by contacting the pa-
tient’s general practitioner and the municipal personal records.
The study was performed according to institutional ethical
review board requirements.
Surgical Technique
The indications for total gastrectomy were tumor loca-
tion proximal from the antrum and linitis plastica. Distal
gastrectomy was performed in tumors located in the
antrum that could be resected with an adequate 5-cm
resection margin. All patients underwent a laparoscopic
resection. All patients underwent an intra-abdominal in-
spection before gastrectomy commenced. When abdom-
inal tumor deposits were seen, patients were not includ-
ed in this study as no curative resection was performed.
Patients underwent en bloc resection of the stomach and
the lesser omentum, combined with a D2 lymph node
dissection.6 The greater omentum was dissected at the
distal side of the gastroepiploic artery through the avas-
cular plane connecting it to the transverse colon. The
omentectomy involved the entire width of its attachment
to the transverse colon. After separate removal, the
greater omentum was marked at four quadrants (left,
right/cranial, caudal) during surgery. Neither pancreatec-
tomy nor splenectomy was performed routinely.
Perioperative chemotherapy (epirubicin, cisplatin, and
fluorouracil) was administered perioperatively in patients
with >cT1 or >cN1 disease when considered possible
based on comorbidity and performance status.2
Pathological Analysis
After operation, the omentum was fixed in 4 % formaldehyde
for at least 12 h. After fixation, the omentum, marked by the
surgeons in four quadrants, was dissected in lamella of 1–2 cm
and macroscopically evaluated by an experienced GI pathol-
ogist (FJWK) for the presence of lymph nodes or tumor de-
posits. Potential tumor deposit or lymph nodes were isolated
and sampled. In case no tumor depositions or lymph nodes
were found, at least one ad random sample per quadrant was
taken. To extract lipids, all samples were incubated in acetone
for 8 h. Subsequently, the samples were routinely processed
for paraffin embedding, using the vacuum infiltration proces-
sor VIP 5. From the paraffin blocks, 4-μm sections were
stained with hematoxylin and eosin (H&E). In difficult cases,
immunohistochemical stainings were performed with pan-
keratin marker CKAE1/3 (LabVision/Neomarkers, Fremont,
CA, USA) and the epithelial tumor marker CAM 5.2 (Becton-
Dickins, Franklin Lakes, NJ, USA).
Statistical Analysis
Statistical analysis was performed with the use of SPSS (ver-
sion 20.0, SPSS Inc, Chicago, IL, USA, 2011). The Pearson
χ2 was used for binary and categorical values, whereas the
nonparametricMann-WhitneyU test was used to analyze con-
tinuous variables with a non-Gaussian distribution. Binary
regression analysis was performed for multivariate analysis.
All covariables with a p value<0.20 in univariate analysis
were included for multivariate analysis. A Kaplan-Meier
curve was constructed to analyze cumulative 1-year survival.
The log rank (Mantel-Cox) was used to calculate the signifi-
cance. P values<0.05 were considered to indicate statistical
significance; 95 % confidence intervals were used. Data were
presented as median with range between brackets.
Results
Patient Characteristics
A total of 50 patients with gastric adenocarcinoma underwent
gastrectomy with omentectomy and were included. Their me-
dian age was 68 (40–87) years and 26 (52 %) were male
(Table 1). Total gastrectomy was performed in 41 (82 %) pa-
tients, whereas distal gastrectomy was performed in 9 (18 %)
patients. The tumor was located in the gastric cardia in 22
(44 %) patients and in the antrum in 12 (24 %) patients
(Table 1). The majority of patients (n=32, 64 %) were diag-
nosed with cT3 gastric cancer. Chemotherapy was adminis-
tered to 35 (70 %) patients preoperatively.
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Pathological Analysis
In 47 (94%) patients, a radical resection (R0) of the tumor was
achieved (Table 2). Themedian length of the greater omentum
was 32 (14–60) cm and the median width was 15 (5–40) cm.
The median number of lymph nodes in the resected specimen
was 19 (5–62) (Table 3). Lymph nodes in the greater omentum
were found in nine (18 %) patients, of which one (2 %) patient
with stage IB was positive for tumor cells. No perioperative
chemotherapy was administered to this patient. Tumor
deposits of gastric carcinoma were found in the greater omen-
tum in four (8 %) patients, clinical stage IB (n=1), IIA (n=1),
IIB (n=1), and IIIA (n=1). Perioperative chemotherapy was
given in 3/4 patients. The lymph node metastasis was located
in the right cranial quadrant of the omentum and the primary
tumor was located in the antrum. The locations of the tumor
deposits were right cranial (n=1), left cranial (n=1), and mul-
tifocal (all quadrants, n=2) (Fig. 1). The locations of the pri-
mary tumors were diffuse (n=2), corpus (n=1), and cardia
(n=1). In univariate and multivariate analyses, no significant
risk factors, such as advanced tumor stage, for the presence of
omental lymph node metastases and tumor deposits were
identified (Table 4).
Survival
After a median follow-up of 9 (0–42)months, 20 (40 %) pa-
tients developed recurrent disease. Local recurrence of the
gastric adenocarcinoma occurred in 8 (16 %) patients, perito-
neal metastases occurred in 13 (26 %) patients, and distant
metastases were found in 6 (12 %) patients (Table 2). A com-
bination of local recurrence and peritoneal/distant metastases
was found in 7 (14 %) patients. The median time to recurrent
disease was 8 (1–17 months. Of the five patients with omental
tumor involvement, one patient with omental tumor deposits
died within 30 days postoperative. The patient with the posi-
tive omental lymph node was still free of disease after
20 months. In the patients with a follow-up >30 days,
Table 1 Baseline characteristics
N = 50



































Preoperative chemotherapy 35 (70 %)










Table 3 Pathological outcomes
N= 50
Overall
Number of lymph nodesa 19 (5–62)
Patients with N+ 29
Number of lymph node metastases in N+ patientsa 4 (1–12)
Greater Omentum
Patients with omental lymph nodes 9
Patients with omental lymph node metastases 1
Omental tumor deposits 4
a Data presented as median (minimum-maximum)
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peritoneal recurrence was seen in all three patients with omen-
tal tumor deposits, compared to 10/45 patients without omen-
tal tumor deposits (100 % vs. 22 %, p=0.017). The three
patients with omental tumor deposits developed peritonitis
carcinomatosa 4, 4, and 8 months after surgery resulting in a
reduced 1-year disease-free survival compared to patients
without omental tumor deposits (0.0 vs. 58.7 %, respectively,
p=0.003). No significant difference in 1-year overall survival
of patients with and without omental tumor deposits was
found (25.0 vs. 67.4 %, respectively, p=0.079).
Discussion
This is the first study that prospectively investigated the pres-
ence of lymph node metastases and tumor deposits in the
greater omentum in a series ofWestern European patients with
gastric adenocarcinoma undergoing gastrectomy. This study
shows an oncologic value of omentectomy, since the greater
omentum harbored lymph nodes in eight (16 %) patients and
lymph node metastases were found in the greater omentum in
one (2 %) patient. Secondly, this study shows a prognostic
value of omentectomy. The greater omentum harbored tumor
deposits in four (8 %) patients, of which none were free of
disease 1 year after surgery, compared to 59 % of patients
without omental tumor deposits. No clinical or pathological
factors were significantly associated with omental tumor
involvement.
The greater omentum has an important function in localiz-
ing and encapsulating sites of infection to limit intra-
abdominal disease. Resection of the greater omentum is an
additional burden to the patient. It might be argued that leav-
ing the omentum in place would be beneficial, especially in
laparoscopic gastrectomy, aiming at a minimally invasive pro-
cedure and reduced morbidity with normal physiology main-
tained. On the other hand, leaving the greater omentum in
place may cause omental infarction. Indeed, a radiologic study
showed omental infarction on postoperative CTscans in 9/390
(2.3 %) of patients who underwent laparoscopy-assisted gas-
trectomy with partial omentectomy for T1-T2 gastric cancer.
However, these infarctions resolved over time in all patients
and did not have clinical consequences.11 In a retrospective
study of patients that underwent gastrectomy for early gastric
cancer, no significant difference in early complication rate was
found between the group with and without omentectomy (3.5
vs. 3.2 %). In contrast, late complications, defined as occur-
ring after discharge or from 30–60 days after surgery, occurred
significantly less in the omentum-preserving group (3.5 vs.
0 %; p=0.026). The described late complications were intra-
abdominal abscesses, ileus, mechanical bowel obstruction,
and anastomotic leakage. No differences regarding mortality
were reported.8
A clinical study in Asian patients (n=196) with advanced
stage gastric cancer found that there was no significant differ-
ence in 3- and 5-year survival rates between gastrectomy with
and without omentectomy.12 In our study, 10 % of the patients
showed tumor involvement in the greater omentum. The pa-
tient with the positive lymph node in the right cranial quadrant
Fig. 1 Location of tumor deposits (TD), lymph node metastases (LNM),
and multifocal locations of tumor deposits (ML) in the greater omentum
in five patients
Table 4 Risk factors for omental
lymph node metastases or tumor
deposits
Characteristic Univariate Multivariate
Odds ratio (95 % CI) p Odds ratio (95 % CI) p
Tumor location
Cardia, fundus 0.286 (0.030–2.761) 0.279 0.394 (0.029–5.439) 0.487
Diffuse 5.333 (0.710–40.057) 0.104 3.903 (0.386–39.456) 0.249
Clinical Stage III 0.667 (0.068–6.580) 0.729 1.415 (0.105–19.012) 0.793
Preoperative chemotherapy 0.609 (0.091–4.081) 0.610 1.019 (0.122–8.528) 0.986
Total versus distal gastrectomy 1.156 (0.114–11.774) 0.902
Poor tumor differentiation 1.125 (0.170–7.452) 0.903
95 % CI 95 % confidence interval
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of the greater omentum was still free of disease after
20 months. These findings support the additive oncologic val-
ue for an adequate omentectomy. None of the patients with
omental tumor depositions was free of disease 1 year after
surgery, compared to 59 % of patients without omental tumor
deposits (p=0.003). Since all patients with omental tumor
deposits developed peritonitis carcinomatosa, this subgroup
of patients might benefit from additional treatment, such as
hyperthermic intraperitoneal chemotherapy (HIPEC), which
may be tested in future studies. To identify patients with
omental tumor involvement for additional treatment, a thor-
ough pathological evaluation of the greater omentum should
be performed along with the gastrectomy.
The strength of our current series is that the greater omen-
tum was specifically marked during surgery for this study to
allow for meticulous pathological evaluation of each quadrant.
In this way, the patterns of lymphatic spread could be very
reliably analyzed. In the current prospective patient series, we
deliberately made clear distinction between the gastrocolic
ligament and the actual greater omentum, also referred to as
infracolic omentum. To objectively evaluate the infracolic
omentum, the greater omentum was dissected distal to the
gastroepiploic artery and removed separately. Results on
omental lymph node counts may otherwise reflect the
perigastric lymph nodes status, rather than those located in
the greater omentum. As the omentumwas resected separately
and marked during surgery, we could very precisely locate the
lymph node metastases and tumor deposits exclusively in the
greater omentum. The lymph node metastases were found in
the right cranial quadrant. The primary tumor was located in
the antrum, which might explain the local spread. The tumor
deposits were found in the left and right cranial quadrants and
multifocally throughout the omentum. The location of the
primary tumor did not influence the location of the tumor
deposits. The multifocal spread is in accordance with the cur-
rent understanding of the lymphatic drainage of the omentum
by means of milky spots, which are located throughout the
entire greater omentum.13 These are sites of macrophages and
lymphocytes located around capillary convolutions and drain
peritoneal fluid into lymph collectors that empty into
subpyloric nodes.8
, 13 Seeding of gastro-intestinal cancer cells
preferentially occurs to the milky spots.8
There is no consensus worldwide on whether to perform an
omentectomy or not during gastrectomy. The European guide-
lines do not give any advice regarding omentectomy,3
, 4 where-
as themost recent American guidelines advise to resect both the
greater and lesser omentum.5 According to the Japanese guide-
lines for gastric cancer, the greater omentum can be left in place
in the specific subgroup of patients with T1 and T2 tumors.
However, our study with Western European patients shows the
presence of omental lymph nodemetastases and tumor deposits
also in patients with early gastric cancer. Since no predictive
factors were associated with the presence of lymph node
metastases or tumor deposits in the greater omentum, we advise
an omentectomy in all patients undergoing gastrectomy.
Conclusion
In conclusion, omental lymph node metastases and tumor de-
posits are found in a substantial part of Western European
patients undergoing gastrectomy for gastric cancer.
Omentectomy has a prognostic and oncologic value in the
curative treatment of patients with gastric cancer. An
omentectomy should be performed in all patients with resect-
able gastric cancer, since no predictive factors were associated
with omental tumor involvement.
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